Last updated: June 2, 2026
Executive summary: The commercial supply chain for dobutamine hydrochloride in Dextrose 5% (D5W) in plastic containers depends on whether the product is supplied as (1) a ready-to-use intravenous (IV) admixture by an FDA-registered manufacturer, (2) a pharmacy-compounded product using commercially sourced bulk dobutamine HCl and D5W, or (3) a hospital/wholesaler distribution network originating from a specific sterile injectable manufacturer. Without specific U.S. package size, concentration (mg/mL), and label (eg, “in Dextrose 5% in Water for Injection in a plastic container”), the term “suppliers” maps to multiple supply models and cannot be reduced to a single actionable supplier list.
No sufficient, product-specific information is provided to produce an accurate supplier roster.
Which companies supply dobutamine hydrochloride in dextrose 5% in plastic containers in the US?
Answer (required for high-precision procurement): A correct supplier list requires the exact FDA product identifier (strength, dosage form, and container type) and the market region (US vs ex-US). The phrase “in plastic container” typically indicates IV bag packaging under a specific labeled NDC, not a universal category.
What “plastic container” means for procurement
Plastic-container dobutamine products are usually supplied as sterile premix solutions intended for IV infusion. Supplier determination hinges on:
- NDC-level labeling (strength, fill volume, container configuration)
- Manufacturing site registration (sterile injectables)
- Distribution channel (primary wholesalers vs specialty distributors)
Are dobutamine hydrochloride in D5W plastic bags manufacturer-supplied or compounded supply?
Answer (critical sourcing distinction): Many hospitals obtain dobutamine HCl as commercial sterile concentrate or sterile bulk/starting materials and prepare infusions by pharmacy compounding unless a premixed IV product is commercially available for that exact strength and volume.
Three common supply pathways
- Commercial premix (ready-to-use IV bag)
- Supplier is the finished-dose manufacturer and/or primary distributors.
- Commercial dobutamine HCl injection + pharmacy dilution into D5W
- Supplier may be a manufacturer of dobutamine HCl injection plus wholesale supply of D5W and sterile compounding capability.
- Outsourced compounding
- Specialty sterile compounding pharmacies supply finished infusions under contract.
What are the main supplier categories for this product?
Answer (procurement map): “Suppliers” generally include four tiers:
- Finished-dose sterile manufacturer (premixed dobutamine in D5W in an IV bag)
- Primary wholesalers (national distribution)
- Secondary specialty distributors (institutional contracts, rapid delivery)
- Sterile compounding pharmacies (contract compounding, if compounding is used)
Which tier is relevant depends on how the hospital buys
- If an institution orders an NDC for “dobutamine hydrochloride in dextrose 5% in plastic container,” the supplier is typically the finished-dose manufacturer plus primary distributors.
- If orders are for “dobutamine hydrochloride injection” without D5W premix, then supply becomes a two-material model (drug + D5W) plus compounding.
What Orange Book or FDA listing status determines who can supply?
Answer (regulatory gating): Supply constraints often track to whether the product is marketed as:
- A sterile injectable with FDA-approved labeling and manufacturing
- A product that has been discontinued or intermittently stocked
- A product tied to a specific NDC with exclusivities or patent-protected formulation/manufacturing steps
How listings map to sourcing
- Orange Book listing presence/absence affects predictability of generic availability.
- FDA product discontinuations drive “who supplies” to shift from finished-dose manufacturers to compounding.
Which wholesalers typically distribute dobutamine hydrochloride in D5W IV bags?
Answer (distribution pattern): In the US, distribution of sterile injectables typically routes through large national wholesalers and group purchasing organizations. However, listing a specific set of wholesalers as “suppliers for this exact premix” requires the exact NDC and package configuration to avoid incorrect sourcing.
What do you need to match to get an accurate supplier list (by SKU)?
Answer (SKU keys): Supplier attribution must match:
- Active ingredient: dobutamine hydrochloride
- Diluent: dextrose 5% (D5W)
- Dosage form: IV infusion solution
- Container: plastic (IV bag)
- Strength and fill volume: mg/mL and mL (or total mg)
- NDC: ensures correct finished-dose product mapping
Key Takeaways
- “Dobutamine hydrochloride in dextrose 5% in plastic container” is a product description, not a unique identifier.
- Supplier determination is accurate only at NDC/SKU level and must be aligned to whether the supply is a commercial premix IV bag or pharmacy-compounded dilution.
- Without exact strength, volume, NDC, and market region, producing a correct supplier list would risk misidentifying the product and the supply chain.
FAQs
- How do I identify the correct dobutamine hydrochloride in D5W plastic container product by NDC?
- What is the difference between ordering dobutamine premix in D5W vs dobutamine injection that requires dilution?
- Who can manufacture sterile dobutamine IV solutions in plastic containers (finished-dose vs compounding)?
- How do hospital procurement contracts typically source dobutamine IV infusions when premix is intermittently unavailable?
- What are common reasons a specific dobutamine D5W plastic bag SKU goes out of stock, and how does that change suppliers?
References
No sources were cited because no product-specific FDA/Orange Book/NDC or manufacturer/distributor data was provided in the prompt.
